Peter Ambrosini - SPDR SP Executive
| KIE Etf | USD 55.88 0.01 0.02% |
Peter A. Ambrosini is Senior Principle Chief Compliance Risk Management Officer, SSgA Funds Management, Inc. Managing Director, PricewaterhouseCoopers .
| Age | 68 |
| Tenure | 21 years |
| Web | www.kier.co.uk |
| Issuer | SSgA |
| Inception Date | 2005-11-08 |
| Benchmark | S&P Insurance Select Industry Index |
| Entity Type | Regulated Investment Company |
| Asset Under Management | 937.27 Million |
| Average Trading Valume | 1.37 Million |
| Asset Type | Equity |
| Category | Sector |
| Focus | Financials |
| Market Concentration | Developed Markets |
SPDR SP Management Efficiency
The company has Return on Asset of (9.0763) % which means that on every $100 spent on assets, it lost $9.0763. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of (44.2348) %, meaning that it generated no profit with money invested by stockholders. SPDR SP's management efficiency ratios could be used to measure how well SPDR SP manages its routine affairs as well as how well it operates its assets and liabilities.Similar Fund Executives
| Showing other executives | One Year Return | ||
| Helen Peters | SPDR SP Bank | 71 | |
| Frank Nesvet | SPDR SP Capital | 68 | |
| Chad Hallett | SPDR SP Bank | 46 | |
| Robert Silver | iShares Insurance ETF | 57 | |
| John Clark | SPDR SP Bank | 45 | |
| John Kerrigan | iShares Insurance ETF | 60 | |
| Chad Hallett | SPDR SP Pharmaceuticals | 46 | |
| Madhav Rajan | iShares Insurance ETF | 52 | |
| Matthew Flaherty | SPDR SP Pharmaceuticals | 41 | |
| Frank Nesvet | SPDR SP Pharmaceuticals | 68 | |
| Robert Kapito | iShares Insurance ETF | 61 | |
| Charles Hurty | iShares Broker Dealers Securiti | 72 | |
| Gary French | SPDR SP Capital | 67 | |
| Mary Zeven | SPDR SP Capital | 51 | |
| Gary French | SPDR SP Bank | 67 | |
| Cecilia Herbert | iShares Insurance ETF | 67 | |
| Matthew Flaherty | SPDR SP Capital | 41 | |
| Helen Peters | SPDR SP Capital | 70 | |
| Gary French | SPDR SP Pharmaceuticals | 67 | |
| John Martinez | iShares Insurance ETF | 55 | |
| Helen Peters | SPDR SP Pharmaceuticals | 71 | |
Management Performance
| Return On Equity | -44.23 | |||
| Return On Asset | -9.08 |
SPDR SP Insurance Money Managers
| Gary French, Treasurer of street tracks series trust | ||
| John Clark, Assistant Treasurer of street tracks series trust | ||
| Helen Peters, Independent Trustee of street tracks series trust | ||
| Matthew Flaherty, Assistant Treasurer of street tracks series trust | ||
| Michael Riley, Vice President of street tracks series trust | ||
| Mary Zeven, Secretary of street tracks series trust | ||
| Chad Hallett, Assistant Treasurer of Street tracks series trust | ||
| Scott Zoltowski, Assistant Secretary of street tracks series trust | ||
| David Kelly, Independent Trustee of street tracks series trust | ||
| Peter Ambrosini, Chief Compliance Officer of street tracks series trust | ||
| James Ross, President Trustee of StreetTracks series trust | ||
| Frank Nesvet, Independent Trustee of street tracks series trust |
SPDR Etf Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right etf is not an easy task. Is SPDR SP a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -44.23 | |||
| Return On Asset | -9.08 | |||
| Shares Outstanding | 104.24 M | |||
| Shares Owned By Institutions | 70.30 % | |||
| Price To Earning | 13.45 X | |||
| Price To Book | 1.16 X | |||
| Price To Sales | 1.17 X | |||
| Revenue | 3.26 B | |||
| EBITDA | (323.86 M) | |||
| Net Income | (247.38 M) |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.| BTC | Bitcoin | |
| TRX | TRON | |
| BNB | Binance Coin |
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in SPDR SP Insurance. Also, note that the market value of any etf could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product. You can also try the Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.
The market value of SPDR SP Insurance is measured differently than its book value, which is the value of SPDR that is recorded on the company's balance sheet. Investors also form their own opinion of SPDR SP's value that differs from its market value or its book value, called intrinsic value, which is SPDR SP's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because SPDR SP's market value can be influenced by many factors that don't directly affect SPDR SP's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between SPDR SP's value and its price as these two are different measures arrived at by different means. Investors typically determine if SPDR SP is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, SPDR SP's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.